The estimated Net Worth of John L. Maldonado is at least $2.33 Bilhão dollars as of 14 May 2021. Mr. Maldonado owns over 448,942 units of Syneos Health Inc stock worth over $271,095,877 and over the last 8 years he sold SYNH stock worth over $2,058,579,114. In addition, he makes $82,750 as Independent Director at Syneos Health Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Maldonado SYNH stock SEC Form 4 insiders trading
John has made over 7 trades of the Syneos Health Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 6,307,489 units of SYNH stock worth $512,168,107 on 7 June 2021.
The largest trade he's ever made was selling 9,257,651 units of Syneos Health Inc stock on 10 August 2017 worth over $341,329,592. On average, John trades about 4,556,788 units every 193 days since 2017. As of 14 May 2021 he still owns at least 6,307,489 units of Syneos Health Inc stock.
You can see the complete history of Mr. Maldonado stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
John Maldonado biography
John L. Maldonado serves as Independent Director of the Company. Since 2006, Mr. Maldonado has been a Managing Partner at Advent, a global private equity firm, focused on buyouts in the healthcare, financial and business services sectors. Prior to joining Advent, he worked at Bain Capital, Parthenon Capital and The Parthenon Group. Mr. Maldonado currently serves on the board of directors of ATI Holdings, Inc., a provider of outpatient physical therapy, where he serves on the Audit Committee and Compliance Committee. He also currently serves on the board of directors of AccentCare, Inc., a provider in post-acute healthcare services, where he serves on the Compensation Committee and Compliance Committee, as well as the board of directors of Definitive Healthcare, LLC, a healthcare data provider, where he serves on the Compensation Committee. Mr. Maldonado previously served on the boards of Genoa, a QoL Healthcare Company, and Cotiviti Holdings, Inc. (formerly NYSE:COTV). Mr. Maldonado received his Bachelor’s degree in mathematics, summa cum laude, from Dartmouth College and his MBA, with high distinction, as a Baker Scholar from Harvard Business School.
What is the salary of John Maldonado?
As the Independent Director of Syneos Health Inc, the total compensation of John Maldonado at Syneos Health Inc is $82,750. There are 19 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.
How old is John Maldonado?
John Maldonado is 44, he's been the Independent Director of Syneos Health Inc since 2017. There are 18 older and 1 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
What's John Maldonado's mailing address?
John's mailing address filed with the SEC is C/O ADVENT INTERNATIONAL CORPORATION, 800 BOYLSTON STREET, SUITE 3300, BOSTON, MA, 02199-8069.
Insiders trading at Syneos Health Inc
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado, eTom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
What does Syneos Health Inc do?
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
What does Syneos Health Inc's logo look like?
Complete history of Mr. Maldonado stock trades at Syneos Health Inc
Syneos Health Inc executives and stock owners
Syneos Health Inc executives and other stock owners filed with the SEC include:
-
Alistair Macdonald,
Chief Executive Officer, Director -
Jason Meggs,
Chief Financial Officer -
Paul Colvin,
President - Clinical Solutions -
Michelle Keefe,
President - Commercial Solutions -
Jonathan Olefson,
General Counsel, Corporate Secretary -
Alistair Macdonald,
CEO & Director -
Jason M. Meggs,
Chief Financial Officer -
Paul D. Colvin,
Chief Bus. Officer -
Michelle Keefe,
Pres of Commercial Solutions -
Jonathan Olefson,
Gen. Counsel & Corp. Sec. -
John Dineen,
Independent Chairman of the Board -
William Klitgaard,
Independent Director -
Kenneth Meyers,
Independent Director -
Linda Harty,
Independent Director -
Matthew Monaghan,
Independent Director -
Joshua Nelson,
Independent Director -
Todd Abbrecht,
Independent Director -
Bernadette Connaughton,
Independent Director -
Thomas Allen,
Independent Director -
John Maldonado,
Independent Director -
Ronnie Speight,
Senior Vice President, Investor Relations -
Robert Parks,
Executive Vice President, Chief Accounting Officer -
Lisa van Capelle,
Chief Human Resource Officer -
Dr. Judith Ng-Cashin M.D.,
Chief Scientific Officer -
Kristen Spensieri,
Global Head of Corp. Communications & Marketing -
Larry A. Pickett Jr.,
Chief Information & Digital Officer -
Dr. Judith Ng-Cashin,
Chief Scientific Officer -
Donna Hildebrand Kralowetz,
Sr. VP of Fin. & Principal Accounting Officer -
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Ma Doubl...,
-
Tom Allen,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Christopher L Gaenzle,
CAO, GC & Sec -
Michael Adam Bell,
Director -
Joshua M Nelson,
-
Todd M Abbrecht,
-
H. Lee Advisors, Llcthl Hol...,
-
H. Lee Advisors, Llc Thomas...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llc Thomas...,
-
H. Lee Advisors, Llcthl Fun...,
-
H. Lee Equity Fund Vi, L.P....,
-
Christian Tucat,
Chief Business Officer -
Michael Lee Brooks,
Chief Operating Officer -
Barbara W. Bodem,
Director -
Alfonso G Zulueta,
Director -
Stanford Rudnick,
See remarks -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Michael J. Bonello,
Chief Financial Officer -
Donna Hildebrand Kralowetz,
EVP, Chief Accounting Officer -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Maap Gpe...,
-
David S. Wilkes,
Director